Fennec (NASDAQ: FENC) CFO gains 1,703 shares as prior awards vest

Rhea-AI Filing Summary

FENNEC PHARMACEUTICALS INC. reported that Chief Financial Officer Robert Andrade acquired 1,703 common shares as a grant or award on May 31, 2026. The shares were released from restrictions tied to prior awards dated May 16, 2024 and March 28, 2025, and carried no purchase price. After this vesting event, Andrade directly holds 289,269 common shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Andrade Robert

Role CHIEF FINANCIAL OFFICER

Type	Security	Shares	Price	Value
Grant/Award	Common shares	1,703	$0.00	--

Holdings After Transaction: Common shares — 289,269 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Shares acquired: 1,703 shares Price per share: $0.0000 per share Total holdings after transaction: 289,269 shares +1 more

4 metrics

Shares acquired 1,703 shares Grant/award acquisition on May 31, 2026

Price per share $0.0000 per share Reported for the 1,703 acquired common shares

Total holdings after transaction 289,269 shares Direct ownership by CFO following the award vesting

Acquire transactions count 1 transaction Non-derivative grant/award acquisition in this Form 4

Key Terms

Common shares, Grant, award, or other acquisition, shares released from restriction

3 terms

Common shares financial

"security_title: "Common shares""

Common shares are the basic units of ownership in a company that give holders a claim on profits and a right to vote on key matters, like electing the board. Think of them as membership cards in a club: they let you share in successes and losses, but in a bankruptcy or liquidation they are paid after creditors and preferred shareholders, so their value can swing more and matters for assessing risk and potential return.

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

shares released from restriction financial

"Represents shares released from restriction from shares awarded 5/16/2024 and 3/28/2025."

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Andrade Robert

(Last) (First) (Middle)

C/O FENNEC PHARMACEUTICALS, INC.

PO BOX 13628, 68 TW ALEXANDER DRIVE

(Street)

RESEARCH TRIANGLE PARK NORTH CAROLINA 27709

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
FENNEC PHARMACEUTICALS INC. [ FENC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF FINANCIAL OFFICER

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common shares(1)	05/31/2026		A		1,703	A	$0	289,269	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares released from restriction from shares awarded 5/16/2024 and 3/28/2025.

	/s/ Robert Andrade	06/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did FENNEC (FENC) report for its CFO?

FENNEC reported that CFO Robert Andrade acquired 1,703 common shares as a grant or award. These shares were released from restrictions tied to earlier awards and increased his direct holdings to 289,269 common shares.

Was the FENNEC (FENC) CFO’s Form 4 transaction an open-market purchase?

No, the transaction was not an open-market purchase. It was classified as a grant or award acquisition, reflecting 1,703 restricted shares becoming unrestricted with a reported price of $0.0000 per share.

How many FENNEC (FENC) shares does the CFO hold after this Form 4?

After the reported transaction, CFO Robert Andrade directly holds 289,269 common shares. This total reflects the addition of 1,703 shares that were released from restrictions tied to prior equity awards.

What is the origin of the 1,703 FENNEC (FENC) shares in the CFO’s Form 4?

The 1,703 shares represent stock previously awarded to the CFO and later released from restrictions. The footnote explains they came from awards granted on May 16, 2024 and March 28, 2025.

Does the FENNEC (FENC) Form 4 indicate any share sales by the CFO?

The Form 4 does not report any share sales by the CFO. It only shows an acquisition of 1,703 common shares through a grant or award, with total direct holdings moving to 289,269 shares.